Next-Generation Sequencing Technologies and Neurogenetic Diseases

Next-generation sequencing (NGS) technology has led to great advances in understanding the causes of Mendelian and complex neurological diseases. Owing to the complexity of genetic diseases, the genetic factors contributing to many rare and common neurological diseases remain poorly understood. Sele...

Full description

Bibliographic Details
Main Authors: Hui Sun, Xiao-Rong Shen, Zi-Bing Fang, Zong-Zhi Jiang, Xiao-Jing Wei, Zi-Yi Wang, Xue-Fan Yu
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Life
Subjects:
Online Access:https://www.mdpi.com/2075-1729/11/4/361
_version_ 1797537202199068672
author Hui Sun
Xiao-Rong Shen
Zi-Bing Fang
Zong-Zhi Jiang
Xiao-Jing Wei
Zi-Yi Wang
Xue-Fan Yu
author_facet Hui Sun
Xiao-Rong Shen
Zi-Bing Fang
Zong-Zhi Jiang
Xiao-Jing Wei
Zi-Yi Wang
Xue-Fan Yu
author_sort Hui Sun
collection DOAJ
description Next-generation sequencing (NGS) technology has led to great advances in understanding the causes of Mendelian and complex neurological diseases. Owing to the complexity of genetic diseases, the genetic factors contributing to many rare and common neurological diseases remain poorly understood. Selecting the correct genetic test based on cost-effectiveness, coverage area, and sequencing range can improve diagnosis, treatments, and prevention. Whole-exome sequencing and whole-genome sequencing are suitable methods for finding new mutations, and gene panels are suitable for exploring the roles of specific genes in neurogenetic diseases. Here, we provide an overview of the classifications, applications, advantages, and limitations of NGS in research on neurological diseases. We further provide examples of NGS-based explorations and insights of the genetic causes of neurogenetic diseases, including Charcot–Marie–Tooth disease, spinocerebellar ataxias, epilepsy, and multiple sclerosis. In addition, we focus on issues related to NGS-based analyses, including interpretations of variants of uncertain significance, de novo mutations, congenital genetic diseases with complex phenotypes, and single-molecule real-time approaches.
first_indexed 2024-03-10T12:11:44Z
format Article
id doaj.art-9cf695fbc4104b54a92baa974ca1460c
institution Directory Open Access Journal
issn 2075-1729
language English
last_indexed 2024-03-10T12:11:44Z
publishDate 2021-04-01
publisher MDPI AG
record_format Article
series Life
spelling doaj.art-9cf695fbc4104b54a92baa974ca1460c2023-11-21T16:09:40ZengMDPI AGLife2075-17292021-04-0111436110.3390/life11040361Next-Generation Sequencing Technologies and Neurogenetic DiseasesHui Sun0Xiao-Rong Shen1Zi-Bing Fang2Zong-Zhi Jiang3Xiao-Jing Wei4Zi-Yi Wang5Xue-Fan Yu6Department of Neurology and Neuroscience Center, The First Hospital of Jilin University, Changchun 130021, ChinaDepartment of Neurology and Neuroscience Center, The First Hospital of Jilin University, Changchun 130021, ChinaDepartment of Neurology and Neuroscience Center, The First Hospital of Jilin University, Changchun 130021, ChinaDepartment of Neurology and Neuroscience Center, The First Hospital of Jilin University, Changchun 130021, ChinaDepartment of Neurology and Neuroscience Center, The First Hospital of Jilin University, Changchun 130021, ChinaDepartment of Neurology and Neuroscience Center, The First Hospital of Jilin University, Changchun 130021, ChinaDepartment of Neurology and Neuroscience Center, The First Hospital of Jilin University, Changchun 130021, ChinaNext-generation sequencing (NGS) technology has led to great advances in understanding the causes of Mendelian and complex neurological diseases. Owing to the complexity of genetic diseases, the genetic factors contributing to many rare and common neurological diseases remain poorly understood. Selecting the correct genetic test based on cost-effectiveness, coverage area, and sequencing range can improve diagnosis, treatments, and prevention. Whole-exome sequencing and whole-genome sequencing are suitable methods for finding new mutations, and gene panels are suitable for exploring the roles of specific genes in neurogenetic diseases. Here, we provide an overview of the classifications, applications, advantages, and limitations of NGS in research on neurological diseases. We further provide examples of NGS-based explorations and insights of the genetic causes of neurogenetic diseases, including Charcot–Marie–Tooth disease, spinocerebellar ataxias, epilepsy, and multiple sclerosis. In addition, we focus on issues related to NGS-based analyses, including interpretations of variants of uncertain significance, de novo mutations, congenital genetic diseases with complex phenotypes, and single-molecule real-time approaches.https://www.mdpi.com/2075-1729/11/4/361next generation sequencingneurogeneticsrare disordersCharcot–Marie–Tooth diseasespinocerebellar ataxiasepilepsy
spellingShingle Hui Sun
Xiao-Rong Shen
Zi-Bing Fang
Zong-Zhi Jiang
Xiao-Jing Wei
Zi-Yi Wang
Xue-Fan Yu
Next-Generation Sequencing Technologies and Neurogenetic Diseases
Life
next generation sequencing
neurogenetics
rare disorders
Charcot–Marie–Tooth disease
spinocerebellar ataxias
epilepsy
title Next-Generation Sequencing Technologies and Neurogenetic Diseases
title_full Next-Generation Sequencing Technologies and Neurogenetic Diseases
title_fullStr Next-Generation Sequencing Technologies and Neurogenetic Diseases
title_full_unstemmed Next-Generation Sequencing Technologies and Neurogenetic Diseases
title_short Next-Generation Sequencing Technologies and Neurogenetic Diseases
title_sort next generation sequencing technologies and neurogenetic diseases
topic next generation sequencing
neurogenetics
rare disorders
Charcot–Marie–Tooth disease
spinocerebellar ataxias
epilepsy
url https://www.mdpi.com/2075-1729/11/4/361
work_keys_str_mv AT huisun nextgenerationsequencingtechnologiesandneurogeneticdiseases
AT xiaorongshen nextgenerationsequencingtechnologiesandneurogeneticdiseases
AT zibingfang nextgenerationsequencingtechnologiesandneurogeneticdiseases
AT zongzhijiang nextgenerationsequencingtechnologiesandneurogeneticdiseases
AT xiaojingwei nextgenerationsequencingtechnologiesandneurogeneticdiseases
AT ziyiwang nextgenerationsequencingtechnologiesandneurogeneticdiseases
AT xuefanyu nextgenerationsequencingtechnologiesandneurogeneticdiseases